Catalent expands biologics facility, to create 36 new jobs
Catalent is expanding its US biologics packaging facility, following recent investments and expansions in the Asia-Pacific region.
Archives for December 4, 2018
AbbVie secures another Humira patent deal
AbbVie’s latest adalimumab licensing deal grants Pfizer access to the Humira biosimilar market in the US on November 20, 2023.